Genes in MS Patients Stony Brook NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Douglas L Bilinski
(203) 259-3755
1300 Post Rd Ste 207
Fairfield, CT
Veronica White-Ruddy
(631) 363-5100
973 Montauk Hwy Suite C
Bayport, NY
Mindy Shaffran
(631) 473-7171
118 North Country Rd
Port Jefferson, NY
Richard Bronson
(631) 444-2737
101 Nicolls Rd # 14
Stony Brook, NY
Alan Vander Vennet
(203) 330-6000
361 Bird St
Bridgeport, CT
Yong Son Basta
(203) 256-9249
111 Beach Rd
Fairfield, CT
Harold Grafstein
(631) 586-2700
300 Bay Shore Rd
North Babylon, NY
Arlene Kaelber
(631) 689-6400
100 South Jersey Avenue
East Setauket, NY
Ann Visser
(631) 862-4000
148 Terry Road
Smithtown, NY
K Matthew
(516) 376-6152
720 Montauk Highway
West Islip, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Side Effect Of Chemotherapy Drugs Stony Brook NY
Lung cancer remains the biggest cancer killer, projected to claim 163,510 lives this year. Paclitaxel will be used in the attempt to save the lives of many of these patients. However, one little-known effect of Paclitaxel is that in a subset of these patients there will be up to a fivefold increase in the production of Interleukin. Read on and learn more.
- Genetic Clues for Skin Cancer Therapies Stony Brook NY
- Gene Therapy for Parkinson's Stony Brook NY
- Gene Variants and Alzheimer's Risk Stony Brook NY
- Hospice: Getting Back Control of Your Life Stony Brook NY
- High Blood Pressure Genes Stony Brook NY
- Depression in Heart Disease Patients Stony Brook NY
- Doctor-Patient Talk for Hypertension Stony Brook NY
- Exercise for Chemotherapy Patients Stony Brook NY
- Differences Between Hospice and Palliative Care Stony Brook NY